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. Among these, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK*), its metabolic reduction product 4-(methyl- 2 To whom correspondence should be addressed nitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and NЈ-nitroCarcinogenic tobacco-specific nitrosamines are present in sonornicotine (NNN) are the most carcinogenic in laboratory tobacco products and are believed to play a significant role animals and are believed to play a significant role in cancers in human cancers associated with tobacco use. Additional of the lung, esophagus, oral cavity and pancreas caused by amounts of tobacco-specific nitrosamines could be formed use of tobacco products (4) . Human exposure to NNK, NNAL endogenously. We tested this hypothesis by treating rats and NNN occurs upon use of tobacco products, including with nicotine and sodium nitrite and analyzing their chewing tobacco, oral snuff and cigarettes. An important urine. Initially, we treated groups of rats with (S)-nicotine question is whether additional amounts of tobacco-specific (60 µmol/kg) and NaNO 2 (180 µmol/kg), (S)-nicotine alone, nitrosamines are formed endogenously in people who use NaNO 2 alone or 4-(methylnitrosamino)-1-(3-pyridyl)-1-tobacco products. butanone (NNK, 12 nmol/kg) by gavage twice daily for 4 The formation of nitrosamines occurs readily in laboratory days. We collected urine and analyzed for two metabolites animals upon administration of nitrite and secondary amines of NNK; 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (5) . Human exposure to nitrite occurs through the diet, via and its glucuronide. We did not detect these metabolites in reduction of dietary nitrate, and from endogenously produced the urine of rats treated with nicotine alone or nicotine nitric oxide (6, 7) . Extensive studies have demonstrated that plus NaNO 2 , indicating that endogenous conversion of nitrosamine formation occurs in humans (8) . Thus, nitrosonicotine to NNK did not occur. However, the urine did proline and related sulfur-containing nitrosamino acids can be contain NЈ-nitrosonornicotine (NNN), NЈ-nitrosoanabasine quantified in human urine. Their levels increase upon ingestion (NAB) and NЈ-nitrosoanatabine (NAT). Analysis of the (S)-of nitrate and proline and are reduced by nitrosation inhibitors nicotine used in this experiment demonstrated that it such as ascorbic acid. Endogenous formation of nitrosoproline contained trace amounts of nornicotine, anabasine and has been associated with a number of exposure scenarios anatabine. In a second experiment, we used an identical linked to cancer risk, including cigarette smoking. It has been protocol to compare the endogenous nitrosation of this (S)-suggested that tobacco-specific nitrosamines could be formed nicotine with that of synthetic (R,S)-nicotine, which did not endogenously from the tertiary amine nicotine, but no data contain detectable amounts of nornicotine, anabasine or have yet been presented in support of this hypothesis (1,2,4). anatabine. NNN (0.53ϫ10 -3 % of nicotine dose), NAB Nicotine can be nitrosated under mild conditions to produce (0.68%) and NAT (2.1%) were detected in the urine of NNK, NNN and 4-(methylnitrosamino)-4-(3-pyridyl)butanal the rats treated with the (S)-nicotine and NaNO 2 . NNN (NNA) (9) . However, the yields are low and the rate of (0.47ϫ10 -3 % of dose), but not NAB or NAT, was present in the urine of the rats treated with synthetic (R,S)-nicotine and NaNO 2 . NNN probably formed via nitrosation of metabolically formed nornicotine. These results demonstrate for the first time that endogenous formation of tobacco-specific nitrosamines occurs in rats treated with tobacco alkaloids and NaNO 2 . The potential significance of the results with respect to nitrosamine formation in people who use tobacco products or nicotine replacement therapy is discussed. occurred (14) . excreted in the urine. Previously, we developed a sensitive
Other nitrosamines. Urine from Experiments 1b and 2 was analyzed for NAB, method to quantify NNAL and NNAL-Gluc in urine (16) . This NAT and NNN by a modification of the method used for NNAL plus NNALmethod was used in the present study to test the hypothesis Gluc. The pH of the urine was adjusted to 7 and it was extracted three that NNK could be formed endogenously in rats treated with times with equal volumes of ethyl acetate. The ethyl acetate extracts were nicotine and nitrite.
concentrated to dryness, redissolved in 1 ml H 2 O and analyzed by reverse phase HPLC on a 7.8ϫ300 mm Bondclone C18 column (Phenomenex, Torrance, CA) with elution by 15% MeOH in H 2 O for 10 min, then a gradient
Materials and methods
to 45% MeOH over 30 min. Eight fractions were collected according to Chemicals retention time markers. The retention time markers were 3-acetylpyridine (S)-Nicotine was a gift from K.D.Brunnemann (American Health Foundation).
(16 min) and 3-pyridylcarbinol acetate (25.8 min). Fraction 1 eluted before (R,S)-Nicotine was synthesized by NaBH 4 reduction of myosmine followed 3-acetylpyridine, fraction 2 eluted with 3-acetylpyridine, fraction 3 comprised by reaction with CH 3 I (17). Anabasine, anatabine, nornicotine, myosmine, material eluting from 0-3 min after 3-acetylpyridine, fraction 4 comprised cotinine, NNN, NNAL, NЈ-nitrosoanabasine (NAB) and NЈ-nitrosoanatabine material eluting after fraction 3 until 3-pyridylcarbinol acetate began to elute, (NAT) were synthesized as described (17) (18) (19) (20) (21) (22) (23) .
fraction 5 eluted with 3-pyridylcarbinol acetate, fraction 6 eluted 0-5 min after 3-pyridylcarbinol acetate and fractions 7 and 8 were the subsequent 4 Animal experiments and 5 min periods respectively. NAT and NAB eluted in fractions 6 and 7 Male F344/CrlBR rats were obtained from Charles River Breeding Laboratories and NNN eluted in fractions 3 and 4. Each fraction was concentrated to (Kingston, NY and Raleigh, NC). They were maintained on tap water and dryness, redissolved in acetonitrile and analyzed by GC-TEA using either a NIH-07 diet under standard conditions (24). In Experiment 1a, the mean packed or capillary column. For analyses on a packed column, we used a weight of the rats (Ϯ SD) was 292 Ϯ 42 g. There were four groups: (1) (S)-12 ftϫ1/8 in. i.d. Silicosteel column (Restek Corp., Bellefonte, PA) packed nicotine (60 µmol/kg body wt) plus NaNO 2 (180 µmol/kg body wt), five rats;
with 3% XE-60 on GasChrom Q, 100/200 mesh (Alltech/Applied Sciences, (2) (S)-nicotine (60 µmol/kg body wt), three rats; (3) NaNO 2 (180 µmol/kg Deerfield, IL). A glass precolumn (Alltech) was attached to the head of the body wt), three rats; (4) NNK (12 nmol/kg body wt), three rats. Nicotine was column. The oven temperature was programmed at 150°C for 2 min, then dissolved in 0.17 M citric acid, pH 3. NaNO 2 was dissolved in distilled H 2 O.
6°C/min to 220°C and held for 15 min. The injection port temperature was NNK was dissolved in 0.17 M citric acid. All solutions (0.5 ml) were 240°C, the flow rate 35 ml/min He and splitless injection was employed. administered by gavage, twice daily for 4 days. In group 1, NaNO 2 was Retention times of NNN, NAT and NAB were 21.8, 20.2 and 21.2 min administered immediately after each dose of nicotine. The rats were housed respectively. For analyses on a capillary column, we used a 15 mϫ0.32 mm in standard metabolism cages during the experiment and urine was collected i.d., 25 µm film thickness, DB-1701 column (J&W Scientific Inc., Folsom, continuously until 24 h after the last gavage. The collection vessel was cooled CA) programmed as follows: 50°C for 2 min, then 6°C/min to 170°C, then with dry ice/acetone and contained 0.5 ml 20% (w/v) ammonium sulfamate in 3.6 N H 2 SO 4 . The combined 4 day urine samples from each rat were analyzed.
held for 10 min. The injection port temperature was 220°C, the flow rate Percentage recoveries of NNN, NAT and NAB were~60-70% using this Fig. 3 . GC-TEA traces obtained upon analysis of urine from rats treated method. The data reported in Table I are isolated amounts, uncorrected with (S)-nicotine plus NaNO 2 . The traces in (A) and (B) were obtained for recovery.
from HPLC fractions corresponding in retention time to NNN or NAT and Nicotine patch. The patches were purchased in pharmacies. They were rolled NAB respectively. into 50 ml centrifuge tubes protected from light. The tubes were flushed with nitrogen for 30 s, then 4 ml degassed H 2 O was added. The mixture was shaken for 1 h. The aqueous extract was transferred to a 15 ml centrifuge and conjugate fractions. This is illustrated for the free NNAL tube and 1 g NaCl was added. The solution was flushed with N 2 and 4 ml fraction in Figure 2B . This peak could be accounted for entirely 220°C and the carrier gas was He at 1 ml/min. Splitless injection was used.
However, the trace in Figure 2C showed some unidentified the extracts by HPLC. We collected fractions corresponding Mϩ1 ions were allowed to enter quadrapole 2 (Q 2 ). The collision gas was argon, 0.88 torr. Q 3 was scanned from m/z 100 to 183. Daughter ions were in retention time to NNN, NAT and NAB and analyzed them compared with those observed in standards. Analyses of the nicotine patches by GC-TEA using both packed and capillary columns. We were performed by GC-MS in the positive CI mode, with methane as reagent observed peaks co-eluting with standard NNN, NAT and NAB gas. GC conditions were as described above.
on both types of columns; this is illustrated for the packed column in Figure 3 . GC-MS/MS analysis confirmed the identity Results of NNN, NAT and NAB in the urine of these rats.
Analysis of rat urine
While NNN is one of the expected products of nicotine nitrosation, the formation of NAB and NAT was difficult to We designed the protocol in Experiment 1 to test the hypothesis that NNK could form endogenously in rats treated with nicotine rationalize. An explanation was found when we analyzed the (S)-nicotine employed for this experiment. It contained and NaNO 2 . The end-point was detection of NNAL and NNAL-Gluc in the urine. The results are illustrated in Figure  nornicotine (0.04%), anabasine (0.07%), anatabine (0.19%), myosmine (0.35%) and cotinine (0.07%). Therefore, NNN 2A-C. NNAL and NNAL-Gluc were detected in the urine of the rats treated with NNK. A GC-TEA trace of the conjugated could have arisen from nitrosation of nicotine or nornicotine, while NAB and NAT were likely formed from anabasine and NNAL fraction is shown in Figure 2A . The peaks marked NG and iso-NNAL-TMS are the injection and silylation standard anatabine respectively. Therefore, in Experiment 2, we compared nitrosation of the respectively. A peak corresponding to NNAL-TMS was clearly evident. We obtained similar traces upon analysis of the free (S)-nicotine with that of synthetic (R,S)-nicotine which did not contain detectable amounts of nornicotine, anabasine or NNAL fraction. The mean total amounts of NNAL and NNALGluc in the 4 day urine of the NNK-treated rats were 280 and anatabine (Ͻ0.0002%). The results are summarized in Table  I . We found NAB (0.68% of nicotine dose) and NAT (2.1%) 290 pmol respectively, corresponding to~1% each of the NNK dose. In the rats treated with nicotine alone, a small peak only in the urine of rats treated with (S)-nicotine which contained anabasine and anatabine. NNN, however, was procorresponding to NNAL-TMS was evident in both the free duced in similar amounts both from (S)-nicotine which concarcinogen, inducing esophageal tumors in rats and lung tumors in mice (26,27,41,42). NAT appears to be non-carcinogenic tained nornicotine (0.53ϫ10 -3 %) and from (R,S)-nicotine which did not contain detectable amounts of nornicotine (26). The endogenous nitrosation of these secondary amines is consistent with previous data demonstrating that this reaction (0.47ϫ10 -3 %). GC-MS/MS confirmed the identity of NNN produced from (R,S)-nicotine.
occurs readily in vitro (11) . Although anabasine and anatabine were contaminants in We investigated the potential for artefactual formation of nitrosamines during collection of the urine in Experiment 2.
the nicotine used in Experiment 1, their nitrosation has potential practical significance. These secondary amines and We collected urine separately for an additional day beyond the standard 4 day collection period. On the additional day, nornicotine occur in substantial quantities in tobacco and tobacco smoke (43,44). Typical levels of anabasine, anatabine we did not add ammonium sulfamate to the collection vessel, did not cool the vessel and did not rinse the collection funnel.
and nornicotine in tobacco are 0.1, 0.5 and 0.6 mg/g tobacco, while in tobacco smoke the corresponding amounts are 3-12, Analysis of this urine demonstrated that the nitrosamine levels were~20% higher than on each of the first 4 days, indicating 4-14 and 27-88 µg/cigarette. The alkaloids of tobacco and tobacco smoke are one reactant that artefact formation was minimal.
in the nitrosation reaction; the other is the nitrosating species.
Analysis of nicotine transdermal systems
In our experiments, conditions for nitrosation were optimized, The above results demonstrated that even trace amounts of but human exposure to nitrosating agents also occurs. One the secondary amines anabasine and anatabine were readily route of human exposure to nitrite is through the diet (6). nitrosated. Therefore, we carried out qualitative analyses of Reduction of dietary nitrate is another major source of nitrite the four leading brands of nicotine transdermal systems. These (6) . Nitrite exposure in the upper gastrointestinal tract from products each contained 20 mg nicotine. We analyzed for these dietary sources has been estimated as 4 mg/day in the nornicotine, anabasine and anatabine. Three of the products USA (6) . Salivary nitrite concentrations in healthy individuals contained detectable levels of these secondary amines, as are 6-10 mg/l, but can increase to 500 mg/l after ingestion of confirmed by GC-MS. The amounts appear to be low: nitrate (45). Endogenous formation of nitrosating agents occurs nornicotine (0.0005-0.004% of nicotine); anabasine (0.002-as a result of the nitric oxide synthase-mediated production of 0.012%); anatabine (0.01%). Thus, a user of a 20 mg nicotine nitric oxide from arginine during infection and inflammation patch could be simultaneously exposed to~0.3 µg nornicotine, (7, 46) . Moreover, tobacco smoke itself is a rich source of 2.4 µg anabasine and 2.0 µg anatabine.
nitrogen oxides and several studies have demonstrated that urinary levels of nitrosoproline and other nitrosamino acids Discussion are~2-fold greater in smokers than in non-smokers (8) .
Nornicotine, anabasine and probably anatabine nitrosate more The results provide the first evidence for endogenous formation of tobacco-specific nitrosamines in rats. Among these, NNN readily than proline (5, 11) and consequently the endogenous formation of NNN, NAB and NAT from the corresponding has considerable carcinogenic activity, producing tumors of the esophagus and nasal cavity in rats, respiratory tract secondary amines is likely in smokers and may contribute significantly to their body burden of nitrosamines. tumors in mice and hamsters and tumors of the nasal cavity in mink (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) . NNN is extensively metabolized in the rat Nicotine replacement therapy is now widely used in smoking cessation programs and nicotine is being considered as a by α-hydroxylation, leading to the formation of DNA adducts (35) (36) (37) . Only 3-5% of NNN is excreted unchanged in the drug for other conditions (47) . Nicotine gum and nicotine transdermal systems (patches) are popular nicotine replacement urine of rats after doses of 3-300 mg/kg are given; no data are available at lower doses (36). Therefore, the amount of NNN systems. The four major brands of nicotine patches available in the USA were qualitatively analyzed for anabasine, anatabine observed in the experiments described in Table I represents a minimum; the actual amount formed in vivo will be at least and nornicotine. The results indicated that levels of these secondary alkaloids were low. However, nitrosation of nicotine 20 times higher.
NNN formation could have occurred by direct reaction of to NNN via metabolically formed nornicotine could occur. Subjects using the nicotine patch concentrate nicotine in nicotine with NaNO 2 in the stomach or by nitrosation of nornicotine that was produced metabolically from nicotine. their saliva (48). Humans, like rats, metabolize nicotine to nornicotine (0.4-2.7% of dose) and it is possible that nornicotThe latter seems more likely. The reaction of nicotine with NaNO 2 is slow. It occurs in low yield and produces NNA and ine could also be concentrated in saliva (49, 50) . Nitrite occurs in saliva. When saliva is swallowed, the stomach provides a NNK as well as NNN (9, 10) . No evidence was found for the production of NNK in this experiment, although the detection favorable pH for nitrosation (5, 11) . Nicotine and nornicotine are protonated in the stomach and poorly absorbed (51). limit was not as low as that for NNN. Nornicotine is a known metabolite of nicotine in the rat. Approximately 9% of a Therefore, conditions for nitrosation of metabolically formed nornicotine might be favorable in some nicotine patch users. nicotine dose is excreted in the urine as nornicotine (38) . It also occurs in the brains of rats treated with nicotine (39). As This could be investigated by analyzing their urine for NNN and its metabolites. a secondary amine, nornicotine reacts with NaNO 2 at a far greater rate than does nicotine (11) .
The results of this study also demonstrate that anabasine Acknowledgements and anatabine are readily nitrosated endogenously in rats. The metabolism of NAT has not been studied. NAB is a weak
